The carcinogenic effect of UVA radiation (from Philips black light tubes filtered through a 2 mm-thick glass plate to eliminate the radiation below 320 nm) was studied in 7 groups of 25 lightly pigmented hairless mice. Irradiation with a moderate daily dose of combined UVB and UVA for 3 months induced a tumor incidence of 0.22 after 58 weeks. When the combined UVB and UVA irradiation was followed by filtered UVA for 2, 4, or 6 months, the tumor incidence was marginally significantly increased to 0.42, 0.48, and 0.50 (p less than 0.05), respectively. However, irradiation with the moderate dose of combined UVB and UVA induced a slight but not significantly lower tumor incidence as compared to UVB alone (0.22 vs 0.30, p greater than 0.1). UVA alone induced no tumors. It thus appears that in hairless mice initially exposed to a combination of UVB and UVA, subsequent continued irradiation with UVA increases tumor incidence. While only marginally statistically significant, tumor incidence in these animals seems to increase with duration and hence total UVA exposure. Furthermore, it is suggested that the photoaugmentative carcinogenic effect of UVA irradiation from unfiltered UVA bulbs can be reduced by attenuating the shorter wavelengths of the radiation.

The disappearance rate of 133Xe was studied in 20 patients with psoriasis vulgaris, using an epicutaneous labeling technique in involved skin lesions or normal-appearing skin of the proximal extensor site of the forearm. Control experiments were performed in 10 normal subjects. Calculations of the cutaneous blood flow (CBF) in psoriatic skin lesions were performed using a tissue-to-blood partition coefficient for 133Xe, lambda c,pso, of 1.2 ml/100 g/min. lambda c,pso was estimated after the relative content of water, lipids, and proteins had been analyzed in psoriatic skin biopsies of 6 patients with untreated psoriasis. The mean relative content of water was markedly reduced to 23.5 +/- 1.5% (SEM), and lipids and proteins were markedly increased to 2.5 +/- 0.7% and 74.0 +/- 2.2, respectively, compared to previously published data for normal skin (water 72.5%, lipids 1%, proteins 26.5%). Mean CBF in untreated psoriatic skin was 63.5 +/- 9.0 ml/100 g/min. This was significantly higher than the mean CBF in 10 normal subjects, 6.3 +/- 0.5 ml/100 g/min (p much less than 0.0001). Mean CBF in normal-appearing skin in patients with psoriasis was 11.0 +/- 1.3 ml/100 g/min. This was significantly higher than CBF in normal subjects (p less than 0.0002).

69 doubtful and positive patch test readings (?+21, +23, ++18, 7) in 15 contact dermatitis patients were studied by measurement of skin thickness as an expression of allergic oedema. Exposed skin was compared with a regional control. Skin thickness was measured by 15 MHz pulsed ultrasound (A-scan) to 0.1 mm accuracy. The ?+, +, ++, and reactions could be separated by measurements of absolute difference in thickness (p less than 0.001, p less than 0.001, p less than 0.02) between exposed and non-exposed skin; the mean increases were 0.14, 0.49, 0.93, and 1.37 mm. The ?+, +, and ++ reactions, but not the reactions, could also be separated by measurements of relative increase in skin thickness (p less than 0.001, p less than 0.001, n.s.); the mean increases were 7%, 25%, 50% and 55%. The normal thickness of the skin of the back was shown to have increased (p less than 0.02) in patients with reactions only. It is concluded that the high-frequency ultrasound method is suitable for quantification of doubtful and positive patch test reactions. The reactions are probably explained by the normal thick skin of the back, and they need no separate recording in patch testing. Standards of increase in skin thickness in doubtful and positive patch tests are defined: absolute increase (mm) was ?+ less than or equal to 0.2; +0.3-0.7; ++0.8-1.3 ( greater than or equal to 1.4); relative increases were ?+ less than 15%; +15-45%, ++ ( included) greater than 45%.

No abstract